Sanofi (FR) is actively pursuing regional expansion, particularly in emerging markets, to capitalize on the growing demand for diabetes treatments
irritans life-cycle comprises theronts, trophonts, protomonts, and tomonts [2, 3]
The research to date indicates that the answer to this question is likely to be yes. With many medical providers and headache specialists already using intravenous or infusion drip therapy to treat headaches and migraines, its certainly worth a try
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
It needs to be clean, balanced and metabolically considerate
doi: 10.3390/biom14020198 17